Douglas E. Williams founded Codiak BioSciences, Inc. Presently, Dr. Williams is Chairman at AC Immune SA and President, Chief Executive Officer & Director at Codiak BioSciences, Inc.
He is also on the board of Ovid Therapeutics, Inc. and Cygnal Therapeutics, Inc.
In the past he was Director, Chief Scientific Officer, EVP-R&D at Seattle Genetics, Inc., Executive Vice President-Research & Development at Biogen, Inc. and Executive Vice President for Biogen Idec New Ventures, Inc. (a subsidiary of Biogen, Inc.), Senior Vice President of Amgen, Inc. and Director, Chief Technology Officer & Executive VP at Immunex Corp. (a subsidiary of Amgen, Inc.), Head-Health & Strategic Development at Genesis Research & Development Corp. Ltd., Chief Executive Officer & Director at ZymoGenetics, Inc. and Secretary & Trustee at Fred Hutchinson Cancer Research Center.
He received a doctorate from State University of New York at Buffalo and an undergraduate degree from the University of Massachusetts Lowell.